4.8 Article

Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation

Related references

Note: Only part of the references are listed.
Article Genetics & Heredity

Epigenomic profiling reveals DNA-Methylation changes associated with major psychosis

Jonathan Mill et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2008)

Review Environmental Sciences

The social environment and the epigenome

Moshe Szyf et al.

ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2008)

Article Multidisciplinary Sciences

Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters

E. Dong et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Biochemistry & Molecular Biology

Functional Analysis of Promoter CpG Methylation Using a CpG-Free Luciferase Reporter Vector

Maja Klug et al.

EPIGENETICS (2006)

Review Pharmacology & Pharmacy

The human reelin gene: Transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia

Dennis R. Grayson et al.

PHARMACOLOGY & THERAPEUTICS (2006)

Article Clinical Neurology

The effect of chronic co-administration of fluvoxamine and haloperidol compared to clozapine on the GABA system in the rat frontal cortex

Yael Chertkow et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)

Article Multidisciplinary Sciences

Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood

ICG Weaver et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Multidisciplinary Sciences

The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases

MV Simonini et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Multidisciplinary Sciences

Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia

E Dong et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Review Neurosciences

GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon

A Guidotti et al.

PSYCHOPHARMACOLOGY (2005)

Review Neurosciences

Cortical inhibitory neurons and schizophrenia

DA Lewis et al.

NATURE REVIEWS NEUROSCIENCE (2005)